What is Iveda Solutions's earnings per share (EPS)?

Iveda Solutions (IVDA) reported diluted earnings per share of $-0.88 for fiscal year 2025. This represents a 51.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Iveda Solutions Financials

IVDA

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Iveda Solutions (IVDA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IVDA FY2025 2026-05-15

External financing is still carrying the business, even as cash burn and operating losses eased in FY2025.

FY2025's better liquidity came from financing cash, not from the core business: financing inflow of $4.6M more than covered operating cash outflow of -$2.0M, which is why cash rose and short-term liquidity improved. Revenue slipped while gross margin reached 24.1% and SG&A fell to $4.3M, showing the year's progress was driven more by cost control than by demand-led scale.

Even after the margin rebound, gross profit was only $1.3M against SG&A of $4.3M, so the operating cost base still sits far above what the current revenue engine can support. The move from 21.6% to 24.1% in gross margin helped, but it did not yet create enough fixed-cost absorption.

The balance sheet posture looks cleaner than a year ago: liabilities fell to $1.6M while cash climbed to $5.2M, so solvency now depends more on equity funding than on borrowing. Accounts receivable dropped from $1.3M to $257K, which helps explain why cash burn improved faster than the reported net loss.

Financial Health Signals

Financial Health Score 47/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Iveda Solutions's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Distress

-10.98

Iveda Solutions scores -10.98, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.3M) relative to total liabilities ($1.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Iveda Solutions passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.63x

For every $1 of reported earnings, Iveda Solutions generates $0.63 in operating cash flow (-$2.0M OCF vs -$3.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-88.4x

Iveda Solutions earns $-88.4 in operating income for every $1 of interest expense (-$3.2M vs $37K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.3M

YoY-12.3%

5Y CAGR+19.3%

Iveda Solutions generated $5.3M in revenue in fiscal year 2025. This represents a decrease of 12.3% from the prior year.

EBITDA

-$3.2M

YoY+20.6%

Iveda Solutions's EBITDA was -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 20.6% from the prior year.

Net Income

-$3.2M

YoY+19.7%

Iveda Solutions reported -$3.2M in net income in fiscal year 2025. This represents an increase of 19.7% from the prior year.

EPS (Diluted)

$-0.88

YoY+51.4%

Iveda Solutions earned $-0.88 per diluted share (EPS) in fiscal year 2025. This represents an increase of 51.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$5.2M

YoY+96.1%

5Y CAGR+125.8%

Iveda Solutions held $5.2M in cash against $266K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+190.9%

5Y CAGR-26.4%

Iveda Solutions had 6M shares outstanding in fiscal year 2025. This represents an increase of 190.9% from the prior year.

Margins & Returns

Gross Margin

24.1%

YoY+2.5pp

5Y CAGR-2.1pp

Iveda Solutions's gross margin was 24.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the prior year.

Operating Margin

-61.1%

YoY+6.5pp

5Y CAGR+165.8pp

Iveda Solutions's operating margin was -61.1% in fiscal year 2025, reflecting core business profitability. This is up 6.5 percentage points from the prior year.

Net Margin

-60.6%

YoY+5.5pp

5Y CAGR-22.2pp

Iveda Solutions's net profit margin was -60.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.5 percentage points from the prior year.

Return on Equity

-66.9%

YoY+92.0pp

Iveda Solutions's ROE was -66.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 92.0 percentage points from the prior year.

Capital Allocation

R&D Spending

$171K

YoY-53.0%

5Y CAGR-10.9%

Iveda Solutions invested $171K in research and development in fiscal year 2025. This represents a decrease of 53.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

IVDA Income Statement

Metric	FY25	FY24	FY23	FY20	FY15	FY14
Revenue	$5.3M-12.3%	$6.0M-7.3%	$6.5M+337.7%	$1.5M-51.7%	$3.1M+40.5%	$2.2M
Cost of Revenue	$4.0M-15.1%	$4.7M-13.1%	$5.4M+447.4%	$992K-58.5%	$2.4M+48.2%	$1.6M
Gross Profit	$1.3M-2.2%	$1.3M+21.9%	$1.1M+116.7%	$493K-27.7%	$682K+18.8%	$574K
R&D Expenses	$171K-53.0%	$363K-54.4%	$797K	N/A	$265K-12.9%	$304K
SG&A Expenses	$4.3M-13.6%	$5.0M+16.2%	$4.3M+150.5%	$1.7M-57.2%	$4.0M-27.4%	$5.5M
Operating Income	-$3.2M+20.7%	-$4.1M-0.7%	-$4.0M-228.9%	-$1.2M+63.2%	-$3.3M+32.7%	-$5.0M
Interest Expense	$37K+39.4%	$26K+260.9%	$7K-98.2%	$399K+0.4%	$397K-17.0%	$479K
Income Tax	$30K-5.9%	$32K+76.9%	$18K	N/A	$13K-20.6%	$16K
Net Income	-$3.2M+19.7%	-$4.0M+3.9%	-$4.1M-158.5%	-$1.6M+57.7%	-$3.8M-350.9%	-$839K
EPS (Diluted)	$-0.88+51.4%	$-1.81+12.6%	$-2.07	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$1.5M+138.7%	$626K-62.1%	$1.7M+8.1%	$1.5M+3.6%	$1.5M-15.3%	$1.7M-27.4%	$2.4M+56.3%	$1.5M
Cost of Revenue	$999K+65.5%	$603K-46.8%	$1.1M+4.7%	$1.1M-8.7%	$1.2M-22.6%	$1.5M-22.8%	$2.0M+92.4%	$1.0M
Gross Profit	$495K+2089.7%	$23K-95.6%	$517K+16.3%	$445K+54.3%	$288K+38.5%	$208K-49.3%	$410K-18.1%	$501K
R&D Expenses	$30K-50.5%	$61K+135.1%	$26K-50.0%	$52K+56.1%	$33K+37.5%	$24K-38.9%	$39K-64.9%	$112K
SG&A Expenses	$1.0M-35.8%	$1.6M+127.6%	$706K-23.7%	$926K-15.1%	$1.1M-36.0%	$1.7M+74.0%	$980K-1.8%	$998K
Operating Income	-$566K+65.6%	-$1.6M-667.5%	-$214K+59.7%	-$532K+36.3%	-$836K+45.1%	-$1.5M-149.8%	-$609K-0.1%	-$608K
Interest Expense	$6K-20.2%	$7K-39.3%	$12K-4.5%	$12K+109.0%	$6K-46.5%	$11K+85.2%	$6K+11.9%	$5K
Income Tax	N/A	N/A	$665-97.8%	$30K	N/A	-$80+38.9%	-$131-110.5%	$1K
Net Income	-$533K+67.1%	-$1.6M-631.5%	-$221K+60.8%	-$564K+28.9%	-$794K+47.5%	-$1.5M-159.9%	-$581K+2.9%	-$599K
EPS (Diluted)	$-0.06	N/A	$-0.07+65.0%	$-0.20+28.6%	$-0.28	N/A	$-0.27	$-0.30

IVDA Balance Sheet

Metric	FY25	FY24	FY23	FY20	FY15	FY14
Total Assets	$6.4M+24.1%	$5.2M-17.9%	$6.3M+406.3%	$1.2M-49.1%	$2.4M-29.7%	$3.5M
Current Assets	$6.2M+22.5%	$5.0M-14.9%	$5.9M+499.8%	$985K-50.5%	$2.0M-19.1%	$2.5M
Cash & Equivalents	$5.2M+96.1%	$2.6M-44.5%	$4.7M+1799.0%	$250K+20.6%	$207K+135.4%	$88K
Inventory	$236K+59.3%	$148K-54.4%	$325K+46.3%	$222K+25.4%	$177K-54.4%	$388K
Accounts Receivable	$257K-79.9%	$1.3M+354.6%	$281K+24.0%	$227K-77.3%	$997K+177.7%	$359K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.6M-38.4%	$2.7M+83.3%	$1.5M-70.5%	$5.0M+21.4%	$4.1M-3.8%	$4.2M
Current Liabilities	$1.3M-44.8%	$2.3M	N/A	$4.5M+32.4%	$3.4M-13.7%	$4.0M
Long-Term Debt	$266K-29.3%	$376K+97.2%	$191K	N/A	N/A	$0
Total Equity	$4.8M+90.8%	$2.5M-46.1%	$4.6M+225.4%	-$3.7M-127.5%	-$1.6M-115.4%	-$756K
Retained Earnings	-$56.4M-6.0%	-$53.2M-8.1%	-$49.2M-28.4%	-$38.3M-20.1%	-$31.9M-16.1%	-$27.5M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$7.9M+22.3%	$6.4M+11.2%	$5.8M+31.6%	$4.4M-3.1%	$4.5M-12.6%	$5.2M-42.8%	$9.1M+34.1%	$6.8M
Current Assets	$7.5M+22.3%	$6.2M+12.3%	$5.5M+34.2%	$4.1M-3.0%	$4.2M-16.2%	$5.0M-34.2%	$7.6M+43.2%	$5.3M
Cash & Equivalents	$5.6M+9.2%	$5.2M+56.3%	$3.3M+107.2%	$1.6M-36.1%	$2.5M-5.3%	$2.6M-26.9%	$3.6M+25.9%	$2.9M
Inventory	$248K+5.1%	$236K-4.7%	$248K-10.0%	$275K+26.3%	$218K+46.9%	$148K-88.6%	$1.3M+68.3%	$770K
Accounts Receivable	$745K+190.3%	$257K-80.6%	$1.3M-3.1%	$1.4M+66.7%	$820K-35.8%	$1.3M-40.8%	$2.2M+103.8%	$1.1M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.0M+21.0%	$1.6M-18.0%	$2.0M-30.9%	$2.9M+2.9%	$2.8M+5.7%	$2.7M-24.3%	$3.5M-10.4%	$3.9M
Current Liabilities	$1.7M+31.0%	$1.3M-19.6%	$1.6M-34.4%	$2.4M+2.7%	$2.3M+1.8%	$2.3M-26.1%	$3.1M+49.7%	$2.1M
Long-Term Debt	$230K-13.7%	$266K-13.2%	$306K-16.1%	$365K+7.2%	$341K-9.4%	$376K-10.4%	$420K-4.8%	$441K
Total Equity	$5.9M+22.7%	$4.8M+26.8%	$3.8M+154.5%	$1.5M-13.0%	$1.7M-32.1%	$2.5M-38.9%	$4.1M+45.5%	$2.8M
Retained Earnings	-$56.9M-0.9%	-$56.4M-3.0%	-$54.8M-0.4%	-$54.5M-1.0%	-$54.0M-1.5%	-$53.2M-6.1%	-$50.1M-1.1%	-$49.5M

IVDA Cash Flow Statement

Metric	FY25	FY24	FY23	FY20	FY15	FY14
Operating Cash Flow	-$2.0M+54.1%	-$4.4M-32.6%	-$3.3M-2189.9%	-$146K+94.5%	-$2.7M+47.1%	-$5.0M
Capital Expenditures	N/A	$3K-97.0%	$86K+290.6%	$22K-20.1%	$27K-89.8%	$269K
Free Cash Flow	N/A	-$4.4M-29.3%	-$3.4M-1941.4%	-$167K+93.8%	-$2.7M+49.2%	-$5.3M
Investing Cash Flow	N/A	-$3K+99.0%	-$266K-1111.9%	-$22K-135.3%	-$9K+96.5%	-$269K
Financing Cash Flow	$4.6M+101.6%	$2.3M+120.8%	$1.0M+800.3%	$114K-95.9%	$2.8M-42.2%	$4.8M
Dividends Paid	N/A	N/A	N/A	N/A	$3K	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$927K-267.3%	-$252K+20.4%	-$317K+76.2%	-$1.3M-957.5%	-$126K+85.8%	-$890K+28.1%	-$1.2M-23.7%	-$1000K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	-$7+100.0%	-$300K-362.5%	$114K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$890K+42.1%	-$1.5M-38.0%	-$1.1M
Investing Cash Flow	$109	N/A	N/A	-$1K-1301.8%	$109+1457.1%	$7-36.4%	$11-100.0%	$186K
Financing Cash Flow	$1.4M-34.4%	$2.2M+5.4%	$2.1M+549.1%	$318K+37801.7%	$839+101.4%	-$59K-103.3%	$1.8M+24008.2%	-$8K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

IVDA Financial Ratios

Metric	FY25	FY24	FY23	FY20	FY15	FY14
Gross Margin	24.1%+2.5pp	21.6%+5.2pp	16.4%-16.8pp	33.2%+11.0pp	22.2%-4.1pp	26.2%
Operating Margin	-61.1%+6.5pp	-67.6%-5.4pp	-62.2%+20.6pp	-82.8%+25.9pp	-108.6%+118.3pp	-226.9%
Net Margin	-60.6%+5.5pp	-66.1%-2.3pp	-63.8%+44.2pp	-107.9%+15.3pp	-123.2%-84.8pp	-38.4%
Return on Equity	-66.9%+92.0pp	-158.9%-69.8pp	-89.1%	N/A	N/A	N/A
Return on Assets	-49.8%+27.1pp	-76.9%-11.2pp	-65.7%+62.9pp	-128.6%+25.9pp	-154.6%-130.5pp	-24.1%
Current Ratio	4.86+2.7	2.19	N/A	0.22-0.4	0.58-0.0	0.62
Debt-to-Equity	0.06-0.1	0.15+0.1	0.04+1.4	-1.34+1.2	-2.50-2.5	0.00
FCF Margin	N/A	-73.5%-20.8pp	-52.6%-41.4pp	-11.3%+76.3pp	-87.6%+154.9pp	-242.5%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	33.1%+29.5pp	3.6%-27.7pp	31.3%+2.2pp	29.1%+9.6pp	19.6%+7.6pp	11.9%-5.2pp	17.1%-15.6pp	32.7%
Operating Margin	-37.9%+224.8pp	-262.7%-249.7pp	-13.0%+21.9pp	-34.8%+21.8pp	-56.7%+30.7pp	-87.3%-61.9pp	-25.4%+14.3pp	-39.7%
Net Margin	-35.7%+222.9pp	-258.6%-245.2pp	-13.4%+23.5pp	-36.9%+16.9pp	-53.8%+32.9pp	-86.8%-62.5pp	-24.2%+14.8pp	-39.1%
Return on Equity	-9.1%+24.8pp	-33.9%-28.0pp	-5.9%+32.2pp	-38.1%+8.6pp	-46.7%+13.6pp	-60.3%-46.1pp	-14.2%+7.1pp	-21.3%
Return on Assets	-6.8%+18.4pp	-25.2%-21.4pp	-3.8%+9.0pp	-12.8%+4.7pp	-17.5%+11.6pp	-29.2%-22.8pp	-6.4%+2.5pp	-8.9%
Current Ratio	4.53-0.3	4.86+1.4	3.48+1.8	1.70-0.1	1.80-0.4	2.19-0.3	2.45-0.1	2.56
Debt-to-Equity	0.04-0.0	0.06-0.0	0.08-0.2	0.25+0.0	0.20+0.1	0.15+0.0	0.10-0.1	0.16
FCF Margin	N/A	N/A	N/A	N/A	N/A	-51.1%+13.0pp	-64.1%+8.5pp	-72.6%

Similar Companies

Bio-Key Intl Inc BKYI

$5.4M

SU Group Holdings Limited SUGP

$3.0M

Verifyme Inc VRME

$8.4M

Guardforce AI GFAI

$12.8M

Supercom SPCB

$66.0M

Frequently Asked Questions

What is Iveda Solutions's annual revenue?

Iveda Solutions (IVDA) reported $5.3M in total revenue for fiscal year 2025. This represents a -12.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Iveda Solutions's revenue growing?

Iveda Solutions (IVDA) revenue declined by 12.3% year-over-year, from $6.0M to $5.3M in fiscal year 2025.

Is Iveda Solutions profitable?

No, Iveda Solutions (IVDA) reported a net income of -$3.2M in fiscal year 2025, with a net profit margin of -60.6%.

What is Iveda Solutions's EBITDA?

Iveda Solutions (IVDA) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Iveda Solutions have?

As of fiscal year 2025, Iveda Solutions (IVDA) had $5.2M in cash and equivalents against $266K in long-term debt.

What is Iveda Solutions's gross margin?

Iveda Solutions (IVDA) had a gross margin of 24.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Iveda Solutions's operating margin?

Iveda Solutions (IVDA) had an operating margin of -61.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Iveda Solutions's net profit margin?

Iveda Solutions (IVDA) had a net profit margin of -60.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Iveda Solutions's return on equity (ROE)?

Iveda Solutions (IVDA) has a return on equity of -66.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Iveda Solutions's operating cash flow?

Iveda Solutions (IVDA) generated -$2.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Iveda Solutions's total assets?

Iveda Solutions (IVDA) had $6.4M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Iveda Solutions spend on research and development?

Iveda Solutions (IVDA) invested $171K in research and development during fiscal year 2025.

How many shares does Iveda Solutions have outstanding?

Iveda Solutions (IVDA) had 6M shares outstanding as of fiscal year 2025.

What is Iveda Solutions's current ratio?

Iveda Solutions (IVDA) had a current ratio of 4.86 as of fiscal year 2025, which is generally considered healthy.

What is Iveda Solutions's debt-to-equity ratio?

Iveda Solutions (IVDA) had a debt-to-equity ratio of 0.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Iveda Solutions's return on assets (ROA)?

Iveda Solutions (IVDA) had a return on assets of -49.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Iveda Solutions's cash runway?

Based on fiscal year 2025 data, Iveda Solutions (IVDA) had $5.2M in cash against an annual operating cash burn of $2.0M. This gives an estimated cash runway of approximately 31 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Iveda Solutions's Altman Z-Score?

Iveda Solutions (IVDA) has an Altman Z-Score of -10.98, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Iveda Solutions's Piotroski F-Score?

Iveda Solutions (IVDA) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Iveda Solutions's earnings high quality?

Iveda Solutions (IVDA) has an earnings quality ratio of 0.63x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Iveda Solutions cover its interest payments?

Iveda Solutions (IVDA) has an interest coverage ratio of -88.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Iveda Solutions?

Iveda Solutions (IVDA) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.